Arkolith/Insider Trading/ABOS/Form 4

Meisner Derek M

Chief Legal Officer & Corp SecAcumen Pharmaceuticals, Inc. (ABOS) · full profile →Form 4 · filed Mar 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 6, 2026Option exercise(M)2K$1.85$4K176K
Mar 6, 2026Sell(S)2K$3.26$7K174K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 6, 2026Option exercise(M)2K—$071K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-016645) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Acumen Pharmaceuticals, Inc.

Build

Ask your agent about ABOS insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001628280-26-016645"
Ask your agent
Use Arkolith to summarize insider buying and selling at Acumen Pharmaceuticals, Inc.
over the last 90 days and cite the filings.